Assessment HOMA as a predictor for new onset diabetes mellitus and diabetic complications in non-diabetic adults: a KoGES prospective cohort study

Table 2 Primary and secondary outcomes according to HOMA-IR groups

HOMA-IR groups
	Low (n = 1454)	Moderate (n = 1414)	High (n = 1446)	p-value	p’	p”
New onset Diabetes	43 (3.0)	37 (2.6)	84 (5.8)	< 0.001	< 0.001	< 0.001
Chronic kidney disease	123 (8.5)	129 (9.3)	173 (12.2)	0.002	0.001	0.007
Macrovascular events	41 (2.9)	26 (1.8)	35 (2.4)	0.156	0.407	0.263
Coronary artery disease or MI	29 (2.0)	15 (1.5)	20 (1.4)	0.052	0.095	0.610
Ischemic stroke	12 (0.8)	11 (0.8)	15 (1.0)	0.809	0.707	0.511

Values are presented as number (%), p-values were calculated using Kaplan–Meier survival analysis with the log rank test. P′ is for the comparison between the low and high HOMA-IR groups. p” is for the comparison between the moderate and high HOMA-IR groups

ISSN: 2055-8260